Evidence map›Paper›PMID 35091820›Full record

ArticleCurrent microbiology2022

Does Bacillus velezensis Strain RP137 from the Persian Gulf Really Produce an Aminoglycoside?

Roderich D Süssmuth, Alexandra Lensch, Stefan Pelzer

Abstract readLetter
PubMed Publisher
In one paragraph

Article in Current microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Roderich D SüssmuthTechnische Universität Berlin, Institut für Chemie, Sekr. TC 2, Straße des 17. Juni 124, 10623, Berlin, Germany.ORCID http://orcid.org/0000-0001-7027-2069
Alexandra LenschEvonik Operations GmbH, Nutrition & Care, Rodenbacher Chaussee 4, 63457, Hanau-Wolfgang, Germany.
Stefan PelzerEvonik Operations GmbH, Nutrition & Care, Kantstr. 2, 33790, Halle, Germany. stefan.pelzer@evonik.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It has recently been published that an aminoglycoside, S‑137‑R, is produced by a newly isolated Bacillus velezensis strain RP137 from the Persian Gulf (Pournejati et al. in Curr Microbiol 76:1028-1037, 2019). However, the analytical data presented by the authors do not allow for a structure elucidation. The data does not even prove that the authors studied an individual compound in terms of analytics and biological activity. The purity of the substance S-137-R is severely doubted because the analytics is inadequate. The molecular mass cannot be assigned on the basis of the published mass spectrum. Fundamental 2D experiments as well as proper data analysis of the presented 1D data are missing. There is no adequate comparison with other data of structurally characterized and confirmed aminoglycosides possible. In conclusion, an assignment of an aminoglycoside is scientifically not justified. Consequently, the EFSA's QPS listing requirement to prove the "absence of aminoglycoside production ability" should be no obligation anymore to approve a B. velezensis species as probiotic.

Indexed as

AminoglycosidesBacillusAnti-Bacterial AgentsIndian OceanAminoglycosidesAnti-Bacterial Agents

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.